ASH 2022 abstracts: What’s hot in GvHD?

To help navigate the exciting content being presented at ASH 2022, the GvHD Hub Steering Committee have provided their recommendations for the top abstracts to...

The safety and efficacy of low-dose interleukin-2 for the treatment of SR-cGvHD

Here, we discuss the combined results of five phase I or II clinical trials (NCT00529035, NCT01366092, NCT01937468,...

How should novel agents be used in the current treatment pathways for GvHD?

During the GvHD Hub Steering Committee meeting on April 5, 2022, key opinion leaders met to debate the question of how novel...

Abatacept as a novel agent for the treatment of steroid-refractory cGvHD: A phase II trial

The results of a phase II clinical trial of abatacept for steroid-refractory chronic graft-versus-host...

Findings from the prospective iMAGINE trial of ibrutinib in pediatric patients with chronic GvHD

Chronic graft-versus-host disease (cGvHD) is a significant cause of mortality and morbidity after...

Editorial theme | T-cell depletion strategies to reduce incidence of GvHD in pediatric HSCT recipients

The current educational theme on the GvHD Hub explores the treatment of pediatric...

How does GvHD affect outcomes for pediatric patients undergoing allo-SCT for ALL?

During the 48th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the ALL Hub spoke...

Editorial theme | Genetic predisposition and endoscopic diagnosis of aGvHD in pediatric patients

In this article, we summarize two publications; one on the genetic susceptibility of pediatric patients...

ASH 2022 abstracts: What’s hot in GvHD?

To help navigate the exciting content being presented at ASH 2022, the GvHD Hub Steering Committee have provided their recommendations for the top abstracts to...

Updated guidelines for post-HSCT vaccination

At the 5th Annual Meeting of the IACH, Ljungman presented the updated vaccine guidelines for posttransplant patients. Here we summarize this presentation.

Patient and physician perceptions of palliative care during transplant

Here, we summarize two studies from the perspective of patient’s experiences with palliative care. In addition, we summarize a...

Updated results from a phase Ib and phase I/II trial of Orca-T

During the 27th Congress of the European Hematology Association (EHA2022), Caspian Oliai presented updated results of a multicenter phase...